[Elsevier] Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Busq Post time 3 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-25 04:06
Reward10points


Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
fdnm9222 Post time 3 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list